Sbir phase II research title android biometric authentication and casualty identification proposal number H2-0406 topic number DHA17-01
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH19C0022
- Awardee
-
Antiradical Therapeutics LLC UEI X9QNA95VGLP8
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $942,514
Award facts
- Opportunity
-
- HQ003417R1DDB Solicitation number
- Contract value 100% obligated
- $942,513.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Buffalo Ridge, SD 57107, USA
- Research
- SBIR Program Phase II Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $234,310 | |
| Supplemental Agreement for work within scope | -$291,613 | |
| Terminate for Convenience | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Original award | $999,817 |
About this award
This is a Firm Fixed Price contract awarded by the Department of the Army Medical Command to Antiradical Therapeutics LLC, a minority-owned, for-profit, Asian-Pacific American-owned limited liability company, for SBIR Phase II research on "Android Biometric Authentication and Casualty Identification" under the SBIR Program. The contract has a potential value of $942,513.53 and a completion date of September 5, 2023. The award was made on December 3, 2018 and the research is categorized under the Major Program Code S10.
Quick answers
Who was awarded contract W81XWH19C0022?
W81XWH19C0022 was awarded to Antiradical Therapeutics LLC by Medical Command (Department of the Army) on December 3, 2018.
How much is contract W81XWH19C0022 worth?
The government has obligated $942,514 on W81XWH19C0022.
Was contract W81XWH19C0022 competed?
The extent of competition for W81XWH19C0022 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award